The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-α

Critical Care Medicine

Volumn 25, Issue 1, 1997, Pages 111-120

  Matuschak, George M ^a,b,c   Lechner, Andrew J ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b ST JOHN S MERCY MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

acute lung injury; Candida sepsis; disseminated candidiasis; fungal dimorphism; fungal septic shock; fungal virulence factors; liver function; myocardial necrosis; opportunistic infection; tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ACID BASE BALANCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CULTURE; BREATHING RATE; CANDIDA ALBICANS; CANDIDIASIS; CARDIOPULMONARY ARREST; CONTROLLED STUDY; CRITICAL ILLNESS; FUNGUS HYPHAE; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; KIDNEY; LIVER; LUNG INJURY; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PULSE RATE; RAT; RECTUM TEMPERATURE; SEPTIC SHOCK;

ANIMALS; BLOOD; CANDIDA ALBICANS; CANDIDIASIS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FUNGEMIA; LIVER; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031029764     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199701000-00022     Document Type: Article

References (60)

1. Fraser VJ, Jones M, Dunkel J, et al: Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414-421
2. Tang E, Tang G, Berne TV: Prognostic indicators in fungemia of the surgical patient. Arch Surg 1993; 128:759-764
3. Pittet D, Wenzel RP: Nosocomial bloodstream infections: Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155:1177-1184
4. Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91:72S-77S
5. Beck-Sague C, Jarvis WR, and the National Nosocomial Infections Surveillance System: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167:1247-1252
6. Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29(Suppl A):19-26
7. Jarvis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526-1530
8. Vincent J-L, Bihari DJ, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 1995; 274:639-644
9. Wade JC: Epidemiology of Candida infections. In: Candidiasis: Pathogenesis, Diagnosis and Treatment. Bodey GP (Ed). New York, Raven Press, 1993, pp 85-107
10. Cornwell EE III, Beizberg H, Offne TV, et al: The pattern of fungal infections in critically ill surgical patients. Am Surg 1995; 61:847-859
11. Eubanks PJ, de Virgilio C, Klein S, et al: Candida sepsis in surgical patients. Am J Surg 1995; 166:617-619
12. Wenzel RP: Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 1995; 20:1531-1534
13. Saltarelli CG: Introduction. In: Candida albicans: The Pathogenic Fungus. Saltarelli CG (Ed). New York, Hemisphere Publishing, 1989, pp 1-32
14. Cutler JE: Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45:187-218
15. Gow NAR, Hube B, Bailey DA, et al: Genes associated with dimorphism and virulence of Candida albicans. Canadian Journal of Botany 1995; 73(Suppl 1):S335-S342
16. Rotrosen D, Edwards JE Jr, Gibson TR, et al: Adherence of Candida to cultured vascular endothelial cells: Mechanisms of attachment and endothelial cell penetration. J Infect Dis 1985; 152: 1264-1274
17. Calderone RA, Braun PC: Adherence and receptor relationships of Candida albicans. Microbiol Rev 1991; 55:1-20
18. Edwards JE Jr, Gaither TA, O'Shea JJ, et al: Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol 1986; 137:3577-3583
19. Gustafson KS, Vercellotti GM, Bendel CM, et al: Molecular mimicry in Candida albicans; role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest 1991; 87: 1896-1902
20. Franzke S, Calderone RA, Schaller K: Isolation of avirulent clones of Candida albicans with reduced ability to recognize the CR2 ligand C3d. Infect Immunol 1993; 61:2662-2669
21. Ponton J, Jones JM: Identification of two germ-tube-specific cell wall antigens of Candida albicans. Infect Immunol 1986; 54:864-868
22. Casanova M, Gil ML, Cardeneso L, et al: Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans. Infect Immun 1989; 57:262-271
23. Torosantucci A, Gomez MJ, Bromuro C, et al: Biochemical and antigenic characterization of mannoprotein constitutents released from yeast and mycelial forms of Candida albicans. J Med Vet Mycol 1991; 29:361-372
24. Molinari A, Gomez MJ, Crateri P, et al: Differential cell surface expression of mannoprotein epitopes in yeast and mycelial forms of Candida albicans. Eur J Cell Biol 1993; 60:146-153
25. Wadsworth E, Prasad SC, Calderone R: Analysis of mannoproteins from blastoconidia and hyphae of Candida albicans with a common epitope recognized by anti-complement receptor type 2 antibodies. Infect Immun 1993; 61:4675-4681
26. Vecchiarelli A, Cenci E, Puliti M, et al: Protective immunity induced by low-virulence Candida albicans: Cytokine production in the development of the anti-infectious state. Cell Immunol 1989; 124:334-344
27. Blasi E, Pitzurra L, Bartoli A, et al: Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans. Infect Immun 1994; 62: 1199-1206
28. Castro M, Bjoraker JA, Rohrbach MS, et al: Candida albicans induces the release of inflammatory mediators from human peripheal blood monocytes. Inflammation 1996; 20:107-122
29. Allendoerfer R, Magee DM, Smith JG, et al: Induction of tumor necrosis factor-alpha in murine Candida albicans infection. J Infect Dis 1993; 167: 1168-1172
30. Strieter RM, Kunkel SL, Bone RC: Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 1993; 21:8447-8463
31. Lechner AJ, Tredway TL, Brink DS, et al: Differential systemic and intrapulmonary TNF-α production in Candida sepsis during immunosuppression. Am J Physiol 1992; 263:L526-L535
32. Matuschak GM, Klein CA, Tredway TL, et al: TNF-α and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis. J Appl Physiol 1993; 74: 2432-2442
33. Lechner AJ, Rouben LR, Potthoff LH, et al: Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock 1993; 39:306-315
34. Ryley JF, Ryley NG: Candida albicans - Do mycelia matter? J Med Vet Mycol 1990; 28:225-239
35. Matuschak GM, Mattingly ME, Tredway TL, et al: Liver-lung interactions during E. coli endotoxemia: TNF-α:leukotriene axis. Am J Respir Crit Care Med 1994; 149:41-49
36. Winer BJ. Statistical Principles in Experimental Design. Second Edition. New York, McGraw-Hill, 1971
37. Tracey KJ, Cerami A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45:491-503
38. Hesse DG, Tracey KJ, Kong Y, et al: Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166:147-153
39. Martich GD, Danner RL, Ceska M, et al: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents. J Exp Med 1991; 173:1021-1024
40. Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-832
41. Schlag G, Redl H, Davies J, et al: Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock 1994; 2:10-18
42. Horgan MJ, Palace GP, Everitt JE, et al: TNF-α release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol 1993; 264:H1161-H1165
43. van der Poll T, Romijn JA, Endert E, et al: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991; 261:E457-E465
44. Wakabayashi G, Gelfand JA, Jung WK, et al: Staphylococcus epidermidis induces complement activation, tumnor necrosis factor, and interleukin-1, a shock-like state, and tissue injury in rabbits without endotoxemia. J Clin Invest 1991; 87:1925-1935
45. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endo-toxin. Science 1985; 229:869-871
46. Bamberger DM, Gurley MB: Microbial etiology and clinical characteristics of distributive shock. Clin Infect Dis 1994; 18:726-730
47. Natanson C, Danner RL, Elin RJ, et al: The role of endotoxin in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989; 83:243-251
48. Telente A, Stecklberg JM, Stockman L, et al: Quantitative blood cultures in candidemia. Mayo Clin Proc 1991; 66: 1120-1123
49. Baine WB, Koenig MG, Goodman JS: Clearance of Candida albicans from the bloodstream of rabbits. Infect Immun 1974; 10:1420-1425
50. Trnovec T, Sikl D, Zemanek M, et al: The distribution of intravenously administered labelled Candida albicans. Sabouraudia 1978; 16:299-305
51. Lechner AJ, Lamprech KE, Potthoff LH, et al: Recombinant GM-CSF reduces lung injury and mortality during neutropenic Candida sepsis. Am J Physiol 1994; 266:L561-L568
52. Olynyk JK, Matuschak GM, Lechner AJ, et al: Differential production of TNF by Kupffer cells after phagocytosis of E. coli and C. albicans. Am J Physiol 1994; 267:G213-G219
53. Matuschak GM, Munoz C, Epperly NA, et al: TNF-α and IL-6 expression in perfused rat liver after intraportal candidemia vs. E. coli or S. aureus bacteremia. Am J Physiol 1994; 267:R446-R454
54. Lechner AJ, Lamprech KE, Johanns CA, et al: Pulmonary TNF-α responses following fungal or Gram-negative bacterial challenge. Abstr. Am J Respir Crit Care Med 1995; 151(Part 2):A322
55. Tronchin G, Bouchara JP, Annaix V, et al: Fungal cell adhesion molecules in Candida albicans. Eur J Epidemiol 1991; 7:23-33
56. Lopez-Ribot JL, Casanova M, Monteagudo C, et al: Evidence for the presence of a high-affinity laminin receptor-like molecule on the surface of Candida albicans yeast cells. Infect Immun 1994; 62:742-746
57. Steinshamn S, Waage A: Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 1992; 60:4003-4008
58. Louie A, Baltch AL, Smith RP, et al: Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun 1994; 62:2761-2772
59. Ferrante A: Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: Increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 1989; 57:2115-2122
60. Filler SG, Ibe BO, Luckett PM, et al: Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis 1991; 164:928-935